maxaquin- lomefloxacin hydrochloride tablet, film coated United States - English - NLM (National Library of Medicine)

maxaquin- lomefloxacin hydrochloride tablet, film coated

g.d. searle llc - lomefloxacin hydrochloride (unii: 9vc7s3zxxb) (lomefloxacin - unii:l6br2wjd8v) - tablet, film coated - 400 mg - maxaquin (lomefloxacin hcl) film-coated tablets are indicated for the treatment of adults with mild to moderate infections caused by susceptible strains of the designated microorganisms in the conditions listed below: (see dosage and administration for specific dosing recommendations.) acute bacterial exacerbation of chronic bronchitis caused by haemophilus influenzae or moraxella catarrhalis. 1 note: maxaquin is not indicated for the empiric treatment of acute bacterial exacerbation of chronic bronchitis when it is probable that s pneumoniae is a causative pathogen. s pneumoniae exhibits in vitro resistance to lomefloxacin, and the safety and efficacy of lomefloxacin in the treatment of patients with acute bacterial exacerbation of chronic bronchitis caused by s pneumoniae have not been demonstrated. if lomefloxacin is to be prescribed for gram–stain–guided empiric therapy of acute bacterial exacerbation of chronic bronchitis, it should be used only if sputum gram stain demonstrates an adequate qualit

Maxaquin New Zealand - English - Medsafe (Medicines Safety Authority)

maxaquin

pharmacia limited company trading as pharmacia - lomefloxacin hydrochloride 400mg;   - tablet - 400 mg - active: lomefloxacin hydrochloride 400mg  

LOMFLOX TABLET 400 mg Singapore - English - HSA (Health Sciences Authority)

lomflox tablet 400 mg

zyfas pharma pte ltd - lomefloxacin hcl eqv lomefloxacin - tablet, film coated - 400 mg - lomefloxacin hcl eqv lomefloxacin 400 mg

Levofloxacine EG 500 mg film-coat. tabl. Belgium - English - AFMPS (Agence Fédérale des Médicaments et des Produits de Santé)

levofloxacine eg 500 mg film-coat. tabl.

eg sa-nv - levofloxacin hemihydrate 512,46 mg - eq. levofloxacin 500 mg - film-coated tablet - 500 mg - levofloxacin hemihydrate 512.46 mg - levofloxacin

Levofloxacine Fresenius Kabi 5 mg/ml inf. sol. i.v. Belgium - English - AFMPS (Agence Fédérale des Médicaments et des Produits de Santé)

levofloxacine fresenius kabi 5 mg/ml inf. sol. i.v.

fresenius kabi sa-nv - levofloxacin hemihydrate 5,125 mg/ml - eq. levofloxacin 5 mg/ml - solution for infusion - 5 mg/ml - levofloxacin hemihydrate 5.125 mg/ml - levofloxacin

Levofloxacine Fresenius Kabi 5 mg/ml inf. sol. i.v. Belgium - English - AFMPS (Agence Fédérale des Médicaments et des Produits de Santé)

levofloxacine fresenius kabi 5 mg/ml inf. sol. i.v.

fresenius kabi sa-nv - levofloxacin hemihydrate 5,125 mg/ml - eq. levofloxacin 5 mg/ml - solution for infusion - 5 mg/ml - levofloxacin hemihydrate 5.125 mg/ml - levofloxacin

Levofloxacine Fresenius Kabi 5 mg/ml inf. sol. i.v. Belgium - English - AFMPS (Agence Fédérale des Médicaments et des Produits de Santé)

levofloxacine fresenius kabi 5 mg/ml inf. sol. i.v.

fresenius kabi sa-nv - levofloxacin hemihydrate 5,125 mg/ml - eq. levofloxacin 5 mg/ml - solution for infusion - 5 mg/ml - levofloxacin hemihydrate 5.125 mg/ml - levofloxacin

Levofloxacine Fresenius Kabi 5 mg/ml inf. sol. i.v. Belgium - English - AFMPS (Agence Fédérale des Médicaments et des Produits de Santé)

levofloxacine fresenius kabi 5 mg/ml inf. sol. i.v.

fresenius kabi sa-nv - levofloxacin hemihydrate 5,125 mg/ml - eq. levofloxacin 5 mg/ml - solution for infusion - 5 mg/ml - levofloxacin hemihydrate 5.125 mg/ml - levofloxacin